| Literature DB >> 20016668 |
M P Montet1, E Jamet, S Ganet, M Dizin, S Miszczycha, L Dunière, D Thevenot, C Vernozy-Rozand.
Abstract
Growth and survival of acid-resistant (AR) and non-acid-resistant (NAR) Shiga-toxin-producing Escherichia coli (STEC) strains were investigated during the manufacture and ripening of microfiltered milk Camembert cheeses. The induction of acid resistance of the STEC strains in cheeses was also studied. Six different mixtures of AR and/or NAR STEC strains were inoculated separately into microfiltered milk at a level of 10(3) CFU mL(-1). The STEC counts (AR and NAR) initially increased by 1 to 2 log(10) CFU g(-1) during cheese-making. Thereafter, the populations stabilized during salting/drying and then decreased during the early stages of ripening. Exposing the STEC strains in artificially inoculated cheeses to simulated gastric fluid (SGF - pH: 2.0) reduced the number of NAR strains to undetectable levels within 40 minutes, versus 120 minutes for the AR STEC strains. AR and NAR STEC were able to survive during the manufacture and ripening of Camembert cheese prepared from microfiltered milk with no evidence of induced acid tolerance in NAR STEC strains.Entities:
Year: 2009 PMID: 20016668 PMCID: PMC2774579 DOI: 10.1155/2009/653481
Source DB: PubMed Journal: Int J Microbiol
Virulence factors and acid resistance of the STEC strains used for the artificial contamination of milk.
| STEC strains | Virulence factors | Acid-resistance | Reference | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strains | Serotypesa | Origins |
|
|
| Shiga-toxin producingb | AR1 | AR2 | AR3 | AR4 | ||
| rate of survival (%) | rate of survival (%) | rate of survival (%) | rate of survival (%) | |||||||||
|
| ||||||||||||
| AR STEC strains | ANR | O6:H10 | Raw milk | N | P | P | P | 96 | 0,5 | 0 | 0 | Vernozy-Rozand
et al. [ |
| 415ASpec | cheese | |||||||||||
| ANR | OntH8 | Raw milk | N | P | P | P | 60 | 76 | 0 | 0 | Vernozy-Rozand et al. [ | |
| 245A1Rif | cheese | |||||||||||
| ANR | O166:H28 | Environment | N | N | P | P | 80 | 1 | 0 | 0 | Vernozy-Rozand et al. [ | |
| V1Spec | ||||||||||||
| ANR | O11:H43 | Environment | N | P | N | P | 67 | 0 | 0 | 0 | Vernozy-Rozand et al. [ | |
| V10Nal | ||||||||||||
|
| ||||||||||||
| NAR STEC strains | ANR | O6:H1 | Raw milk | N | P | P | P | 0 | 0 | 0 | 0 | Vernozy-Rozand et al. [ |
| 360BRif | cheese | |||||||||||
| ANR | O6:H1 | Raw milk | N | P | P | P | 0,7 | 0 | 0 | 0,2 | Vernozy-Rozand et al. [ | |
| 42ANal | cheese | |||||||||||
| ANR | O6:H10 | Raw milk | N | P | N | P | 0 | 0 | 0 | 0 | Vernozy-Rozand et al. [ | |
| 418ARif | cheese | |||||||||||
| ANR | O174:H8 | Raw milk | P | P | P | P | 0 | 0 | 0 | 0 | Vernozy-Rozand et al. [ | |
| 346ASpec | cheese | |||||||||||
aOnt: O type not corresponding to any serogroup between O1 and O 174.
bP production.
cP, positive.
N, negative.
AR1: oxidative system (glucose-repressed system), AR2: system depending on the presence of glutamate, AR3: system depending on the presence of arginine, AR4: system depending on the presence of lysine.
Rif: Rifampicin resistance, Spec: Spectinomicin resistance, Nal: Nalidixic acid resistance.
Composition of the STEC strains mixtures used for the inoculation of milk.
| Cocktail denomination | Cocktail composition | STEC strains |
|---|---|---|
| AR1-AR2 | 3 AR STEC strains | ANR V10Nal-ANR 245A1Rif-ANR 415ASpec |
| AS1-AS2 | 3 NAR STEC strains | ANR 42ANal-ANR 360BRif-ANR 346ASpec |
| ARSSa1-ARSSa2 | 1 AR STEC strains | ANR V10Nal |
| 2 NAR STEC strains | ANR 360BRif-ANR 346ASpec | |
| ARSSb1-ARSSb2 | 1 AR STEC strains | ANR V1Spec |
| 2 NAR STEC strains | ANR 42ANal-ANR 360BRif | |
| ASRRa1-ASRRa2 | 2 AR STEC strains | ANR 245A1Rif-ANR 415ASpec |
| 1 NAR STEC strains | ANR 42ANal | |
| ASRRb1-ASRRb2 | 2 AR STEC strains | ANR V10Nal-ANR 415ASpec |
| 1 NAR STEC strains | ANR 418ARif |
Figure 1Flowchart for the manufacture of lactic cheeses made with microfiltered milk.
Physicochemical properties of Camembert cheeses.
| Component | Cheese at the end of moulding (day 1) | Cheese at the end of ripening (day 20) |
|---|---|---|
| Dry matter (% w/w) | 38.37 ± 0.49 | 42.02 ± 0.54 |
| Fat content (% w/w) | 19.44 ± 0.31 | 21.25 ± 0.29 |
| Fat on dry matter (% w/w) | 50.65 ± 0.55 | 50.58 ± 0.40 |
| Moisture content (% w/w) | 76.53 ± 0.43 | 73.65 ± 0.50 |
| Salt content (% w/w) | 2.58 ± 0.13 | |
| pH | 4.66 ± 0.05 | 5.11 ± 0.03 |
Average values in 4 uninoculated cheeses as negative controls.
Mean ± standard deviation.
Changes in pH values during cheese processing.
| Stages of sampling | |||||||
|---|---|---|---|---|---|---|---|
| Milk before maturation | Curd during draining | Cheese at the end of moulding | Cheese after salting | Cheese after drying | Cheese at the middle of ripening (D+10) | Cheese at the end of ripening (D+20) | |
|
| |||||||
| Inoculated cheeses | 6.45 ± 0.02 | 6.03 ± 0.02 | 4.65 ± 0.05 | 4.64 ± 0.04 | 4.66 ± 0.05 | 4.75 ± 0.02 | 5.11 ± 0.03 |
| Uninoculated cheeses | 6.44 ± 0.03 | 6.02 ± 0.04 | 4.64 ± 0.06 | 4.63 ± 0.06 | 4.65 ± 0.05 | 4.73 ± 0.04 | 5.10 ± 0.02 |
pH values for each cheese, inoculated or not, and at each time of sampling (i.e., 10 pH measures per time of sampling).
Mean ± standard deviation.
Figure 2Counts of STEC strains during the cheese manufacture. AR2: 3 AR STEC strains, AS2: 3 NAR STEC strains, ARSSb2: 1 AR and 2 NAR STEC strains, ASRRa2: 2 AR and 1 NAR STEC strains. AR strains: black lines, symbols: ▵, ◯, ×. NAR strains: grey lines, symbols: ▿, ⊠, ⋄. Step 1: milk prior to maturation, Step 3: cheese at moulding stage, Step 5: cheese after drying, Step 7: cheese at the end of ripening (20 days).
Survival rates of STEC strains in simulated gastric fluid at pH: 2.
| Acid-resistance | Strain | Survival rate (%)a | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Time (min) | ||||||||||
| T(5) | T(10) | T(20) | T(30) | T(40) | T(50) | T(60) | T(90) | T(120) | ||
|
| ||||||||||
| AR | ANR 415ASpec | 95 | 95 | 71 | 60 | 50 | 32 | 24 | 10 | 4 |
| ANR 245A1Rif | 86 | 75 | 65 | 63 | 46 | 43 | 36 | 13 | 10 | |
| ANR V1Spec | 97 | 80 | 130 | 115 | 110 | 108 | 105 | 100 | 34 | |
| ANR V10Nal | 81 | 74 | 71 | 66 | 56 | 49 | 29 | 18 | 8 | |
|
| ||||||||||
| NAR | ANR 360BRif | 35 | 13 | 25 | 0.37 | 0.18 | 0.03 | ≤0.01 | ≤0.01 | ≤0.01 |
| ANR 42ANal | 55 | 36 | 6.67 | 0.31 | ≤0.01 | ≤0.01 | ≤0.01 | ≤0.01 | ≤0.01 | |
| ANR 418ARif | 66 | 41 | 7.18 | 0.40 | 0.14 | ≤0.01 | ≤0.01 | ≤0.01 | ≤0.01 | |
| ANR 346ASpec | 26 | 27 | 59 | 4 | 0.59 | ≤0.01 | ≤0.01 | ≤0.01 | ≤0.01 | |
aPercentage of survival calculated as 100× the number of CFU per gram remaining after the acid treatment divided by the initial CFU per gram at time zero.